- Two Lung Masses with Different Responses to Pemetrexed
-
Park KY, Jung JW, Nam SB, Lee HJ, Kim HS, Choi YH, Lee JC
- KMID: 1785681
- Korean J Intern Med.
- 2010 Jun;25(2):213-216.
- doi: 10.3904/kjim.2010.25.2.213
We described here a patient who had two lung masses. Although the two masses had the same histology and a similar good response to initial chemotherapy with gemcitabine and carboplatin,... -
- CITED
-
- Close
- SHARE
-
- Close
- Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer
-
Ahn J, Wee WR, Lee JH, Hyon JY
- KMID: 1098641
- Korean J Ophthalmol.
- 2011 Oct;25(5):355-357.
- doi: 10.3341/kjo.2011.25.5.355
We report a case of vortex keratopathy in a patient treated with vandetanib for non-small cell lung cancer (NSCLC). A 44-year-old female who underwent two cycles of chemotherapy for NSCLC... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Vinorelbine, Mitomycin C and Cisplatin Chemotherapy for Advanced Non-Small Cell Lung Cancer
-
Kwon MR, Jeong TY, Yuh YJ, Kim SR
- KMID: 759617
- Korean J Intern Med.
- 2002 Dec;17(4):240-244.
BACKGROUND: This prospective phase II trial was performed to determine the efficacy and toxicity of mitomycin C, vinorelbine and cisplatin combination chemotherapy for patients with previously untreated stage IIIB... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images
-
Bilici A, Seker M, Ustaalioglu BBO, Canpolat N, Salepci T, Gumus M
- KMID: 1777890
- J Korean Med Sci.
- 2011 Apr;26(4):574-576.
- doi: 10.3346/jkms.2011.26.4.574
Extra marginal-zone lymphomas of the lung is a very rare tumor and it originates from bronchial-associated lymphoid tissue. A 68-yr-old woman presented with productive cough and dyspnea. A thorax computed... -
- CITED
-
- Close
- SHARE
-
- Close
- High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma
-
Seo MS, Kim JK, Shim JY
- KMID: 2163643
- Yonsei Med J.
- 2015 Sep;56(5):1449-1452.
- doi: 10.3349/ymj.2015.56.5.1449
We report a case of regression of multiple pulmonary metastases, which originated from hepatocellular carcinoma after treatment with intravenous administration of high-dose vitamin C. A 74-year-old woman presented to the... -
- CITED
-
- Close
- SHARE
-
- Close
- A Less Intensive Combination of Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer Patients who Have Aged 60 Years or More and Has a Poor Performance Status
-
Min YJ, Ahn JJ, Noh YJ, Cha HJ, Suh JH, Jung JP, Park CR, Jeong AK, Park JH, Lee KM
- KMID: 759697
- Korean J Intern Med.
- 2004 Jun;19(2):109-113.
BACKGROUND: The aim of this study was to evaluate the response, survival, and toxicities of a less intensive combination of paclitaxel and carboplatin, which is used in advanced non-small cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
-
Ko YH, Lee MA, Hong YS, Lee KS, Park HJ, Yoo IR, Kim YS, Kim YK, Jo KH, Wang YP, Lee KY, Kang JH
- KMID: 1785624
- Korean J Intern Med.
- 2007 Sep;22(3):178-185.
- doi: 10.3904/kjim.2007.22.3.178
BACKGROUND: Second-line chemotherapy offers advanced non-small cell lung cancer (NSCLC) patients a small, but significant increase in survival. Docetaxel is usually administered as a 3-week schedule, yet there is... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria
-
Lee HY, Lee KS, Hwang HS, Lee JW, Ahn MJ, Park K, Kim TS, Yi CA, Chung MJ
- KMID: 1119224
- Korean J Radiol.
- 2010 Dec;11(6):618-626.
- doi: 10.3348/kjr.2010.11.6.618
OBJECTIVE: We wanted to compare the efficacy of the new CT response evaluation criteria for predicting the tumor progression-free survival (PFS) with that of RECIST 1.1 in non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
